These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1008726)

  • 1. [Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
    Duarte GM; Ribeiro LG; Coelho W; Thevenard R; Souza PJ; Gonçalves MA; Carneiro RD; Luna RL
    Arq Bras Cardiol; 1976 Aug; 29(4):338-45. PubMed ID: 1008726
    [No Abstract]   [Full Text] [Related]  

  • 2. [Verapamil in the treatment of patients with coronary insufficiency].
    Savenkov PM; Doscicin VL; Zarov EI; Arsakuni RO
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1287+. PubMed ID: 4098328
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the effect of verapamil on the tolerance for exertion in coronary patients].
    Miraglia G; Stritoni P; Egloff C; Scattolin G; Contessotto F; Passarin N; Dalla Volta S
    Boll Soc Ital Cardiol; 1979; 24(5):583-9. PubMed ID: 553643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ergometric evaluation of the therapeutic effect of prolonged oral administration of delayed-action verapamil on 20 patients with stable effort angina].
    Martiny W; Bottone W; Matta F; Cerrone G; Minelli M; Angelino PF
    Minerva Cardioangiol; 1978 Dec; 26(12):811-8. PubMed ID: 368679
    [No Abstract]   [Full Text] [Related]  

  • 5. [Verapamil in a single dose, evaluation by means of the ergometric test].
    Pereira MH; Brito FS; Pereira CB; Lion MF
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():83-94. PubMed ID: 889475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ergometric and clinical results of treating coronary disease with isosorbide dinitrate and verapamil].
    Pozenel H
    Med Welt; 1981 Jun; 32(24):988-92. PubMed ID: 7253907
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of isoptin on intrahepatic and central hemodynamics in ischemic heart disease].
    Komissarov VA
    Klin Med (Mosk); 1987 Sep; 65(9):64-7. PubMed ID: 3695314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of verapamil on the cycloergometric test in patients of coronary artery disease].
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():71-4. PubMed ID: 329811
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
    Bobkova VI; Solomonova LN; Majorov JM; Karpickij VS; Mazurova SV
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1285+. PubMed ID: 4098327
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
    Ribeiro JM; Sadi J; Barros FA
    Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of verampamil in the treatment of patients with chronic coronary insufficiency].
    Schvacabaja IK; Mjasnikov LA; Metelica VI; Grigorjanc RA; Dubinina LT
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1478+. PubMed ID: 5536558
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency].
    Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of finoptin on cerebrocardiac correlations in atherosclerotic circulatory encephalopathy in patients with ischemic heart disease].
    Dubenko OE; Ermakovich II
    Vrach Delo; 1988 Mar; (3):39-42. PubMed ID: 3394295
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical mechanisms of action of coronarodilating agents (review of the literature)].
    Chekman IS; Kazak LI
    Vrach Delo; 1976; (5):23-9. PubMed ID: 9729
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of drugs upon exercise tests in coronary insuffiency.
    Oliveira JM
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():79-81. PubMed ID: 329813
    [No Abstract]   [Full Text] [Related]  

  • 19. [Assessment of therapeutic effects of Verapamil by means of an exercise test].
    Goch JH; Rec A; Bala T
    Pol Tyg Lek; 1975 Sep; 30(36):1497-8. PubMed ID: 1161614
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
    Zygelman M; Mérillon JP; Guiomard A; Eustigneff T; Zannier D; Gourgon R
    Arch Mal Coeur Vaiss; 1981 Jun; 74(6):685-94. PubMed ID: 6794490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.